Poster: MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel).

Autor: Jakubowiak, Andrzej, Parekh, Samir, Madduri, Deepu, Santomasso, Bianca, Pérez-Larraya, Jaime Gállego, van de Donk, Niels W.C.J., Arnulf, Bertrand, Mateos, Maria-Victoria, De Braganca, Kevin C., Varsos, Helen, Carrasco-Alfonso, Marlene J., Akram, Muhammad, Lendvai, Nikoletta, Jackson, Carolyn C., Olyslager, Yunsi, Zudaire, Enrique, Li, Claire, Geng, Dong, Einsele, Hermann, Cohen, Adam
Zdroj: Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS249-S249, 1p
Databáze: Complementary Index
Externí odkaz: